Shaanxi Kanghui Pharmaceutical (603139) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

CN Stock MarketDetailed Quotes

603139 Shaanxi Kanghui Pharmaceutical

Watchlist

14.93
+0.54+3.75%

Market Closed Dec 27 15:00 CST

1.49BMarket Cap-20.23P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Surges 28% Yet Its Low P/S Is No Reason For Excitement
Simply Wall StNov 12 17:19 ET
Kanghui Pharmaceuticals: Kanghui Pharmaceuticals Report for the Third Quarter of 2024
SZSIOct 30 12:00 ET · Announcements
Kanghui Pharmaceutical\'s announcement on the main operating data for the first three quarters of 2024
SZSIOct 30 12:00 ET · Announcements
Kanghui Pharmaceutical 2024 Third Quarter Report
SZSIOct 30 12:00 ET · Announcements
Kanghui Pharmaceutical 2024 Semi-Annual Report
SZSIAug 29 12:00 ET · Announcements
Summary of Kanghui Pharmaceutical\'s 2024 Semi-Annual Report
SZSIAug 29 12:00 ET · Announcements

Comments

Moomoo AI

Mar 17 19:35

Despite a rise in share price, Shaanxi Kanghui Pharmaceutical's P/S ratio lags behind others, possibly due to expectations of continued limited growth. A reversal in share price fortunes seems unlikely if trends persist.

Improved Revenues Required Before Shaanxi Kanghui Pharmaceutical Co., Ltd. (SHSE:603139) Stock's 33% Jump Looks Justified

Moomoo AI

Feb 1 16:48

The company's lower P/S ratio is due to its limited growth rates, which are expected to persist. Investors are paying less for the stock due to these rates. Unless conditions improve, the share price may stay at these levels.